HCM - Hutchison China MediTech Limited

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 53.9B
Enterprise value 33.71B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)18.21
Price/book (mrq)11.25
Enterprise value/revenue 317.33
Enterprise value/EBITDA 6-34.79

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 332.12%
S&P500 52-week change 325.98%
52-week high 332.55
52-week low 316.47
50-day moving average 325.35
200-day moving average 321.87

Share statistics

Avg vol (3-month) 3191.14k
Avg vol (10-day) 3214.16k
Shares outstanding 5133.38M
Float 52.21M
% held by insiders 16.81%
% held by institutions 129.99%
Shares short (30 Dec 2019) 41.63M
Short ratio (30 Dec 2019) 49.37
Short % of float (30 Dec 2019) 4N/A
Short % of shares outstanding (30 Dec 2019) 41.22%
Shares short (prior month 28 Nov 2019) 41.42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 329 May 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2018
Most-recent quarter (mrq)29 Jun 2019

Profitability

Profit margin -40.86%
Operating margin (ttm)-51.83%

Management effectiveness

Return on assets (ttm)-12.93%
Return on equity (ttm)-20.37%

Income statement

Revenue (ttm)214.12M
Revenue per share (ttm)1.61
Quarterly revenue growth (yoy)0.40%
Gross profit (ttm)-44M
EBITDA -106.66M
Net income avi to common (ttm)-87.48M
Diluted EPS (ttm)-0.66
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)237.29M
Total cash per share (mrq)1.78
Total debt (mrq)7.82M
Total debt/equity (mrq)2.10
Current ratio (mrq)2.80
Book value per share (mrq)2.62

Cash flow statement

Operating cash flow (ttm)-44.3M
Levered free cash flow (ttm)-40.58M